Uveitis Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01148225A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisTreatment
NCT01138657Efficacy and Safety of Adalimumab in Patients With Active UveitisTreatment
NCT01124838Efficacy and Safety of Adalimumab in Subjects With Inactive UveitisTreatment